Toronto, ON, September 23 — BioPharma Services Inc., a leading Contract Research Organization (CRO), is proud to announce the successful completion of a GCP inspection by the FDA at our clinical facility. The weeklong audit concluded with no Form 483 issued.  This...

HEALWELL’s subsidiary, BioPharma Services, is expanding into late-stage patient trials through the integration of Canadian Phase Onward, a dedicated clinical research site built within the framework of HEALWELL’s Polyclinic Family and Specialty Medicine Facility. ...

Toronto, ON, June 13 - BioPharma Services is thrilled to announce that HEALWELL AI signed a share purchase agreement with Think Research on June 13, 2024, to acquire BioPharma Services. HEALWELL AI, with WELL Health Technologies Corp. (TSX: WELL) as its largest...

Toronto, Canada, May 7, 2024 - BioPharma Services, a leading contract research organization specializing in early clinical trials, is pleased to announce that it has been awarded a groundbreaking First-in-Human (FIH) study. This milestone follows a significant...

[TORONTO, July 17, 2023] — BioPharma Services, a leading Clinical Research Organization (CRO) globally renowned for advancing healthcare through clinical studies, recently completed a comprehensive inspection conducted by the World Health Organization (WHO) and Health...

Following the recent inspection of the clinical site in St. Louis, Missouri (and previous to that, the Toronto clinic site in May 2022), FDA Inspectors came on site to inspect the BioPharma Services’ bioanalytical laboratory in Toronto, Canada. During the week of...